上海凯宝 (300039)

Shanghai Kaibao Pharmaceutical Co.,Ltd.

ASZ

Tags

Venture Capital ConceptInnovative DrugsPharmaceutical ManufacturingInvestments in Newly Listed CompaniesInfant and Child ConceptHepatitis ConceptMargin Trading and Securities LendingChiNext Small CapChiNext Healthcare

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 104600.00
  • Circulating A-Shares(W): 91692.62
  • Earnings Per Share(RMB): 0.1788
  • Net Assets Per Share(RMB): 4.3451
  • Operating Revenue(W RMB): 81902.91
  • Total Profit(W RMB): 22036.39
  • Net Profit Attributable to Parent(W RMB): 18704.18
  • Net Profit Growth Rate(%): -13.83
  • Weighted Return on Equity(%): 10.7900
  • Operating Cash Flow Per Share(RMB): 0.1930
  • Undistributed Profit Per Share(RMB): 2.0949
  • Capital Reserve Per Share(RMB): 0.0082

2. Main Business

The main business covers:

  • Modern Traditional Chinese Medicine (TCM) R&D
  • Modern TCM Production
  • Modern TCM Sales

3. Company Basic Information

  • Company Name: Shanghai Kaibao Pharmaceutical Co., Ltd.
  • Listing Date: 2010-01-08
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone
  • Website: www.xykb.com
  • Company Profile：The company was established by the overall change of Shanghai Kaibao Pharmaceutical Co., Ltd. In August 2008, upon resolution of the shareholders' meeting, Shanghai Kaibao Pharmaceutical Co., Ltd. was transformed into Shanghai Kaibao Pharmaceutical Co., Ltd. and obtained the "Business License of Enterprise Legal Person" with registration number 310226000171574 issued by the Shanghai Administration for Industry and Commerce on September 8, 2008. The registered capital of the joint stock company was 82,200,000 yuan. Lixin Certified Public Accountants conducted the audit and capital verification for this overall change, issuing the Xinhui Shi Bao Zi (2008) No. 23625 "Audit Report" and Xinhui Shi Bao Zi (2008) No. 23656 "Capital Verification Report".

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xinxiang Kaiyi Commerce and Trade Co., Ltd. General Legal Person 6850.40 7.47
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 699.22 0.76
3 Southern China Securities CSI 1000 ETF Fund 574.45 0.63
4 ChinaAMC CSI Traditional Chinese Medicine ETF Fund 390.98 0.43
5 China Universal CSI 1000 ETF Fund 341.02 0.37

5. Concept Sectors

  • Venture Capital Concept
  • Infant and Child Concept
  • Hepatitis Concept
  • Innovative Drug
  • Margin Trading & Securities Lending
  • Investing in New Shares
  • ChiNext Pharmaceutical
  • ChiNext Small Cap

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information